Learn More
Medchemexpress LLC Pyrido[4,3-d]pyrimidin-7(6H)-one, 8-(4-bromophenyl)-6-(4-methoxyphenyl)-2-[(2,2,2-trifluoroethyl)ami | 2377492-26-5 | 99.9% | C22H16BrF3N4O2 | 1 ML

Supplier: Medchemexpress LLC HY14577810MM/1ML
AGI-41998 is a potent and orally active inhibitor of methionine adenosyltransferase 2A (MAT2A) that effectively penetrates the blood-brain barrier. It exhibits significant inhibitory activities against MAT2A and S-adenosyl methionine (SAM) in HCT-116 MTAP-null cells. This compound can significantly inhibit HCT-116 cell proliferation and tumor growth, making it useful for studying SAM regulation in the central nervous system and colon cancer.
- Potent and orally active MAT2A inhibitor
- Effectively penetrates the blood-brain barrier
- Exhibits inhibitory activity against MAT2A and S-adenosyl methionine (SAM)
- Significantly inhibits HCT-116 cell proliferation
- Inhibits tumor growth in xenograft models
- Reduces tumor and brain SAM levels
- Decreases SAM levels in tumors by approximately 80%
- No significant weight loss observed in animal models
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.